Kisqali (LEE011)

ribociclib · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kisqali (LEE011), covering 2017-05-12 to 2017-05-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer [Phase 3]